SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2477MNTA ‘ReadMeFirst’ updated: <i>IMS data show robust launch for generic LoDewDiligence_on_SI-9/7/2010
2476>>However, the problem as we have all noted is the last criterion. I cannIRWIN JAMES FRANKEL19/6/2010
2475In the letter responding/denying Teva's CP dated May 11, 2010 (I've postidos-9/6/2010
2474A couple of posts from the FDA law blog . . . one on the possibility of atuck-9/4/2010
2473Rocky, the only other thing I can think of would be public disclosure that Teva fred hayes-9/3/2010
2472Thanks Jim. Your points make sense. Your downside looks a little severe to my efred hayes-9/3/2010
2471Option trade - thinking about doing the reverse of the put buy disclosed yesterdRocky9-9/3/2010
2470Too many surprises already for my taste, but I'd probably welcome that onetom pope-9/3/2010
2469Pipeline and core spending can have a negative net valuation especially on a modrkrw19/3/2010
2468Tom, you won't find the answer, even in Dew's readme first files. An expfred hayes-9/3/2010
2467As Dew mentioned, the news of Lovenox labels and needle sticks is not new. WhatD.Lu-9/2/2010
2466<i>Company value is in 4 pieces: Lovenox, M118, Copaxone, and platform/IP.tom pope-9/2/2010
2465Dew, that is exactly what I was hoping for. Very much appreciated, I’m confidenfred hayes-9/2/2010
2464I posted some valuation numbers in siliconinvestor.com . FWIWDewDiligence_on_SI-9/2/2010
2463To me as a recent holder of MNTA stock I find this news very interesting if not Biotech Jim-9/2/2010
2462The problem with Sandoz's Lovenox syringe is old news. It clearly hasn'tDewDiligence_on_SI-9/2/2010
2461When bad gets worse. As a nursing professional, I received a letter today from D.Lu-9/2/2010
2460fwiw, that is similar to my thinking -- which is why I am a buyer of a trading pmopgcw-9/2/2010
2459mnta 101 – Here’s how I’m looking at it current market cap at $14.70, using 5fred hayes29/2/2010
2458deletedtom pope-8/31/2010
2457Impressive timing and discipline on your part :-)DewDiligence_on_SI-8/31/2010
2456No posts in 3 days here. I reckon it's time to buy my first little lot...SeachRE-8/31/2010
2455LOL—actually, I’ve been making this point for a few years, while Sanofi figured DewDiligence_on_SI-8/28/2010
2454Borrowing from Sanofi's brief, Dew? :-)tom pope-8/28/2010
2453It’s easy to over-analyze these kinds of things. If the FDA intended to demand eDewDiligence_on_SI-8/27/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News